BriaCell Therapeutics Corp.
BCTXZ- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001610820
No open-market purchases or sales by BriaCell Therapeutics Corp. insiders were filed in the last 90 days; 5 institutions reported holding it in 13F filings for Q2 2026, worth $61.7K in total; no superinvestor holds it.
Members of Congress who traded BCTXZ
No member of Congress has reported a trade in BriaCell Therapeutics Corp. since 2020.
Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.